Rhythm Pharmaceuticals (RYTM) Competitor Comparison
We are evaluating the key criteria listed to compare Rhythm Pharmaceuticals (RYTM) against its competitors in the Biotechnology industry.
Market Capitalization
64 / 368Gross Profits
85 / 278Total Revenue
110 / 300EBITDA
275 / 337Free Cashflow
278 / 352Quick Ratio
148 / 357Earnings per Share
291 / 359Dividend yield
0 / 6Total Cash
114 / 358Performance 3 years
13 / 368Performance 5 years
50 / 368Performance 10 years
50 / 368Linearity 3 years
368 / 368Linearity 5 years
350 / 368Linearity 10 years
336 / 368Total Rank
251 / 368Dividend Rank
263 / 368Valuation Rank
68 / 368Piotroski Rank
44 / 368Muliplier Rank
196 / 368Linearity 3 years - RYTM ranking 368 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.